Tag: Biopharmaceutical Development

America’s AI Action Plan Boosts Pharmaceutical Innovation

Accelerating Pharmaceutical and Biopharmaceutical Innovation through America’s AI Action Plan America’s AI Action Plan, unveiled in July 2025, lays out a comprehensive strategy to propel...

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment...

Future of Drug Packaging: Safety, Sustainability, Innovation

The development of medication packaging stands out as a form of tribute to the industry's dedication to safety, sustainability, and technical innovation in an...

CDMOs and Advanced Technologies in Biopharma Manufacturing

The biopharmaceutical sector is driven by rising global healthcare needs, technology, technological advancements, and the imperative to remain agile in a highly regulated environment....

Biopharma Production with AI: A New Era in Manufacturing

A New Era of Biopharma Production with AI The biopharma industry is undergoing a transformation as it capitalises on the potential of artificial intelligence (AI)...

Asia’s Bio Sovereignty: Nations Reclaiming Biologics Control

The biopharmaceutical industry in the Asia-Pacific area has seen a significant strategic shift in recent years; this trend is now commonly acknowledged as Asia's...

Digital Twins in Biomanufacturing: APAC’s Leap in Innovation

The Asia-Pacific (APAC) region is fast embracing biomanufacturing, leading-edge technology that is poised to redefine manufacturing processes and efficiency. One of the most revolutionary...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read